Percutaneous Access Closure in TAVR: Are Devices Similar?

One of the challenges that transcatheter aortic valve replacement (TAVR) continues to face is percutaneous access closure with percutaneous closure systems (PCS).

Cierre del acceso percutáneo en TAVI ¿Son similares los dispositivos?

However, several systems have been developed, either by plug—such as the MANTA system—or by suture (SU)—such as the ProStar and ProGlide systems.

Both of these have been tested in different analyses, but to date they are similar and still continue to have certain difficulties.

Researchers conducted a meta-analysis of two randomized and eight observational studies including a total of 3113 patients. Of these, 1358 received the MANTA (43.6%) system, while 1755 received either the ProStar or ProGlide (56.4%) systems.

The primary endpoint (PEP) was major vascular complication according to VARC-2 criteria.

Mean patient age was 80 years old and most subjects were male. Self-expanding valves were used the most, and in most cases heparin was reverted.

Read also: Have Complications Related to Balloon Pulmonary Angioplasty Changed Since its Inception?

There were no differences in the PEP (3.1% vs. 3.3 %; odds ratio [OR]: 0.89; 95% confidence interval [CI]: 0.52−1.53; p = 0.67).

The PCS failure rate was lower in the PL D group (6.2% vs. 8.9 %; OR: 0.60; 95% CI: 0.44−0.83; p = 0.002; I2 = 14%). However, in this group there was a greater trend towards unplanned vascular access intervention (8.2% vs. 5.9 %; OR: 1.35; 95% CI: 0.97−1.89; p = 0.07; I2 = 3%).

There were no differences in the rates for mortality, bleeding (major, minor or life-threatening), transfusion, bruising, pseudoaneurysm, lower limb ischemia, or arteriovenous fistulae.

Read also: Prosthesis Mismatch in TAVR: It’s Real Impact.

In randomized trials, the rates of bleeding, major bleeding, and minor vascular complications were lower in those who received a plug PCS vs. SU PCS.

Conclusion

In patients undergoing TAVR, closure using plug-based PCSs was associated with a similar safety profile than SU-based PCSs. However, subgroup analysis demonstrated that the plug-based PCSs were associated with a higher incidence of vascular and bleeding complications in randomized studies.

Dr. Carlos Fava - Consejo Editorial SOLACI

Dr. Carlos Fava.
Member of the Editorial Board of SOLACI.org.

Original Title: Outcomes with plug‐based versus suture‐based vascular closure device after transfemoral transcatheter aortic valve replacement: A systematic review and meta‐analysis.

Reference: Ramy Sedhom MD, et al. Catheter Cardiovasc Interv. 2023;101:817–827.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

Valve-in-Valve in Small Surgical Aortic Bioprostheses: Balloon-Expandable or Self-Expanding? Three-Year Results from the LYTEN Trial

Dysfunction of small surgical aortic bioprostheses represents a challenging scenario for transcatheter aortic valve replacement in the valve-in-valve setting, due to the higher incidence...

Can TAVI Be Safely Performed in Patients With Bicuspid Aortic Valve?

Bicuspid aortic valve (BAV) represents an anatomical challenge for transcatheter aortic valve replacement (TAVR) due to the frequent presence of elliptical annuli, fibroc calcific...

Transcatheter Paravalvular Leak Closure: Mid-Term Outcomes and Prognostic Factors

Paravalvular leaks (PVL) are a frequent complication following surgical valve replacement, occurring in 5% to 18% of prosthetic valves. Incidence varies according to valve...

After a Major Bleeding Event in Atrial Fibrillation: When Should Left Atrial Appendage Closure Be Considered?

Atrial fibrillation (AF) in patients who experience a major bleeding event represents a complex clinical scenario in which percutaneous left atrial appendage closure (LAAC)...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Valve-in-Valve in Small Surgical Aortic Bioprostheses: Balloon-Expandable or Self-Expanding? Three-Year Results from the LYTEN Trial

Dysfunction of small surgical aortic bioprostheses represents a challenging scenario for transcatheter aortic valve replacement in the valve-in-valve setting, due to the higher incidence...

AHA/ACC Guideline on the Management of Acute Pulmonary Embolism 2026

The 2026 ACC/AHA guideline for the management of acute pulmonary embolism (PE) introduces a conceptual shift by replacing the traditional “risk-based” classification with an...

How real are the adverse effects of statins? Evidence from randomized clinical trials

The safety of statins continues to be a subject of debate, partly due to the extensive list of adverse effects included in prescribing information,...